Showing results (281-290 of 345) with videos related to

Sort By:
Pageof 35
European Journal of Heart Failure|April 13, 2021
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristicsKarola S Jering, Brian Claggett, Marc A Pfeffer, et al.
Journal of the American College of Cardiology|November 22, 2023
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection FractionJaved Butler, Steen Z Abildstrøm, Barry A Borlaug, et al.
Scientific Reports|October 3, 2020
Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
ESC Heart Failure|September 15, 2025
Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MIFrancesco Fioretti, Javed Butler, Jacob A Udell, et al.
ESC Heart Failure|September 19, 2025
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAIMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure|December 26, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trialMark C Petrie, Jacob A Udell, Stefan D Anker, et al.
Circulation|November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI TrialRoxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
Lancet (London, England)|August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort studyBernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
European Journal of Heart Failure|December 19, 2020
Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHFBeth A Davison, Stefanie Senger, Iziah E Sama, et al.
European Heart Journal|August 26, 2020
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registryKaren Sliwa, Mark C Petrie, Peter van der Meer, et al.
Pageof 35